20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan

PHASE3CompletedINTERVENTIONAL
Enrollment

1,425

Participants

Timeline

Start Date

June 14, 2021

Primary Completion Date

May 13, 2022

Study Completion Date

May 13, 2022

Conditions
Pneumococcal Disease
Interventions
BIOLOGICAL

20vPnC

20vPnC

OTHER

Saline

Saline

BIOLOGICAL

13vPnC

Pneumococcal conjugate vaccine

BIOLOGICAL

PPSV23

Pneumococcal polysaccharide vaccine

Trial Locations (28)

220

Far Eastern Memorial Hospital, New Taipei City

333

Linkou Chang Gung Memorial Hospital, Taoyuan

704

National Cheng Kung University Hospital, Tainan City

10002

National Taiwan University Hospital, Taipei

15355

Korea University Ansan Hospital, Ansan-si

16247

The Catholic University of Korea, St. Vincent's Hospital, Suwon

16499

Ajou University Hospital, Suwon

22332

Inha University Hospital, Incheon

23561

Taipei Medical University Shuang Ho Hospital, New Taipei City

40447

China Medical University Hospital, Taichung

41944

Kyungpook National University Hospital, Daegu

1500001

Hillside Clinic Jingumae, Shibuya-ku

1920071

P-one Clinic, Keikokai Medical Corporation, Hachioji-shi

819-1104

Seishinkai Inoue Hospital, Itoshima

231-0861

Women's Clinic LUNA NEXT STAGE, Naka-ku, Yokohama-Shi

532-0003

Medical Corporation Heishinkai OPHAC Hospital, Osaka

565-0853

Medical Corporation Heishinkai OCROM Clinic, Suita-shi

103-0025

Nihonbashi Sakura Clinic, Chuo-ku

104-0031

Fukuwa Clinic, Chuo-ku

160-0008

Medical Corporation Heishinkai ToCROM Clinic, Shinjuku-ku

812-0025

SOUSEIKAI PS Clinic, Fukuoka

08308

Korea University Guro Hospital, Seoul

03722

Severance Hospital, Yonsei University Health System, Seoul

05355

Kangdong Sacred Heart Hospital, Seoul

05505

Asan medical Center, Seoul

06591

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

07441

Hallym University Kangnam Sacred Heart Hospital, Seoul

07985

Ewha Womans University Mokdong Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04875533 - 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan | Biotech Hunter | Biotech Hunter